-       Report 
- October 2025
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
            -       Report 
- August 2025
-  125 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- October 2025
-  180 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- May 2025
-  200 Pages 
- Global 
   From       €2227EUR$2,490USD£1,959GBP 
          -       Report 
- February 2025
-  120 Pages 
- Global 
   From       €2227EUR$2,490USD£1,959GBP 
           -       Report 
- September 2025
-  183 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- May 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- January 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- November 2024
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- October 2025
-  189 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  401 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
       
      Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) that affects the large intestine. It is characterized by inflammation and ulceration of the inner lining of the colon and rectum. Symptoms of UC include abdominal pain, bloody diarrhea, fatigue, and weight loss. Treatment options for UC include medications, lifestyle changes, and surgery.
The UC market is a subset of the larger Gastroenterology market. It is a growing market, driven by an increasing prevalence of IBD and the    development of new treatments. The market is highly competitive, with a number of companies offering treatments for UC.
Some of the companies in the UC market include AbbVie, Allergan, AstraZeneca, Janssen, Pfizer, and Takeda. Show Less   Read more